Uche Okuu Arunsi

Mr. Uche Okuu Arunsi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2021 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
SOSe Owumi
Se Owumi
DLDo Lewu
Do Lewu
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
AOAk Oyelere
Ak Oyelere
Doxorubicin is an effective anti-neoplastic agent; the reported toxicities of DOX limit its use. Luteolin is a polyphenolic phytochemical that exhibits beneficial biological effects via several mechanisms. We investigate luteolin protective effects on hepatorenal toxicity associated with doxorubicin treatment in rats. For 2 weeks, randomly assigned rat cohorts were treated as follows: control, luteolin (100 mg/kg; per os), doxorubicin alone (2mg/kg; by intraperitoneal injection), co-treated cohorts received luteolin (50 and 100 mg/kg) in addition to doxorubicin. Treatment with doxorubicin alone significantly (p < 0.05) increased biomarkers of hepatorenal toxicities in the serum. Doxorubicin also reduced relative organ weights, antioxidant capacity, and anti-inflammatory cytokine interleukine-10. Doxorubicin also increased reactive oxygen and nitrogen species, lipid peroxidation, pro-inflammatory-interleukin-1β and tumour necrosis factor-α-cytokine, and apoptotic caspases-3 and -9). Morphological damage accompanied these biochemical alterations in the rat’s liver and kidney treated with doxorubicin alone. Luteolin co-treatment dose-dependently abated doxorubicin-mediated toxic responses, improved antioxidant capacity and interleukine-10 level. Luteolin reduced (p < 0.05) lipid peroxidation, caspases-3 and -9 activities and marginally improved rats’ survivability. Similarly, luteolin co-treated rats exhibited improvement in hepatorenal pathological lesions observed in rats treated with doxorubicin alone. In summary, luteolin co-treatment blocked doxorubicin-mediated hepatorenal injuries linked with pro-oxidative, inflammatory, and apoptotic mechanisms. Therefore, luteolin can act as a chemoprotective agent in abating toxicities associated with doxorubicin usage and improve its therapeutic efficacy.

1 March 2019 in Journal of Cleaner Production
Verified
Journal Article
Closed access
EUEziuche Amadike Ugbogu
Eziuche Amadike Ugbogu
MEMona M.M.Y. Elghandour
Mona M.M.Y. Elghandour
VIVictor Okezie Ikpeazu
Victor Okezie Ikpeazu
GBGerman R. Buendía
German R. Buendía
OMOfelia M. Molina
Ofelia M. Molina
Abdelfattah Z.M. SalemAbdelfattah Z.M. Salem
Abdelfattah Z.M. Salem

6 May 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
AKAbisola I. Kazeem
Abisola I. Kazeem
BWBOCHENG WU
BOCHENG WU
LILucia O. Ishokare
Lucia O. Ishokare
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
Adegboyega OyelereAdegboyega Oyelere
Adegboyega Oyelere
Sorghum bicolor plant has a high abundance of 3-deoxyanthocyanins, flavonoids and other polyphenol compounds that have been shown to offer numerous health benefits. Epidemiological studies have linked increased intake of S. bicolor to reduced risk of certain cancer types, including lung adenocarcinoma. S. bicolor extracts have shown beneficial effects in managing hepatorenal injuries. This study investigated the cytotoxic potential of three apigeninidin-rich extracts of S. bicolor (SBE-05, SBE-06 and SBE-07) against selected cancer cell lines and their ameliorative effect on aflatoxin B1 (AFB1)-mediated hepatorenal derangements in rats. We observed that, among the three potent extracts, SBE-06 more potently and selectively suppressed the growth of lung adenocarcinoma cell line (A549) (IC50 = 6.5 μg/mL). SBE-06 suppressed the expression of STAT3 but increased the expression of caspase 3. In addition, SBE-05, SBE-06 and SBE-07 inhibited oxidative and nitrosative stress, inflammation, and apoptosis and preserved the histoarchitectural networks of the liver and kidney of rats treated with AFB1. These in vitro and in vivo studies indicate the potential of these cheap and readily accessible extracts for cancer therapy and as chemo-preventive agents in preventing aflatoxin-related health issues.

2 February 2022 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
CIChioma E. Irozuru
Chioma E. Irozuru
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
HFHammed O Faleke
Hammed O Faleke
AOAdegboyega K. Oyelere
Adegboyega K. Oyelere


13 February 2021 in Toxicology Research
Verified
Journal Article
Closed access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
JOJoseph K Olusola
Joseph K Olusola
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
Adegboyega OyelereAdegboyega Oyelere
Adegboyega Oyelere
Plant-derived phenolics are utilized as chemopreventive agents to abate adverse toxic responses associated with drug-induced damages. Tamoxifen (TAM)—a chemotherapeutic agent—is used in managing all stages of hormone-dependent breast cancer. Notwithstanding TAM’s clinical side effect—including hepatic toxicity—its use is commonplace. The present study investigates the effect of Chlorogenic acid (CGA: 25 and 50 mg kg−1; per os (p.o)) reported to exhibit various beneficial properties, including antioxidative effect against TAM (50 mg/kg; p.o.)-induced hepatorenal toxicities in rats treated as follows: Control, CGA, or TAM alone, and rats co-treated with CGA and TAM for 2 weeks. Biomarkers of hepatorenal function, oxido-inflammatory stress, and hepatorenal histopathology were performed. We observed that TAM alone decreased relative organ weights (ROW), marginally impacted rat’s survivability, and significantly (P < 0.05) increased hepatorenal toxicities and reactive oxygen and nitrogen species (RONS). TAM decreased (P < 0.05) antioxidant, anti-inflammatory cytokine (IL-10), besides increase in (P < 0.05) lipid peroxidation (LPO), pro-inflammatory cytokines (IL-1β, TNF-α), nitric oxide (NO), xanthine oxidase (XO), myeloperoxidase (MPO), and apoptotic caspases (Casp-3 and -9) levels. These biochemical alterations were accompanied by morphological lesions in experimental rats’ liver and kidney. Conversely, that CGA dose-dependently relieved TAM-mediated toxic responses, restored antioxidants capacities, reduced oxidative stress, pro-inflammatory cytokines levels, and Casp-3 and -9 activities in experimental rats. Furthermore, CGA protected against lesions observed in the liver and kidney of rats treated with TAM alone. Overall, CGA blocked TAM-mediated hepatorenal injuries associated with pro-oxidative, inflammatory, and apoptotic mechanisms. CGA may serve as a chemoprotective agent boosting patients prognosis undergoing TAM chemotherapy.